REDDYNUX fondaparinux sodium 2.5 mg/0.5 mL solution for injection pre-filled syringe

Země: Austrálie

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktivní složka:

fondaparinux sodium, Quantity: 2.5 mg

Dostupné s:

Dr Reddys Laboratories Australia Pty Ltd

INN (Mezinárodní Name):

Fondaparinux sodium

Léková forma:

Injection, solution

Složení:

Excipient Ingredients: sodium chloride; water for injections

Podání:

Subcutaneous

Jednotky v balení:

2, 10, 20

Druh předpisu:

(S4) Prescription Only Medicine

Terapeutické indikace:

Fondaparinux is indicated for the prevention of venous thromboembolic events (VTE) in patients undergoing major orthopaedic surgery of the lower limbs such as hip fracture, major knee or hip replacement surgery.,Fondaparinux is indicated for the prevention of venous thromboembolic events (VTE) in patients undergoing abdominal surgery who are at risk of thromboembolic complications.

Přehled produktů:

Visual Identification: Clear and colorless to slightly yellow solution; Container Type: Syringe; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Stav Autorizace:

Licence status A

Datum autorizace:

2015-02-16